Generic
30 April 2017 | 0 Comments
Welcome to this week’s edition of the NORML legislative roundup! At the federal level, it is important to highlight two key developments pertaining to established marijuana consumers, businesses, and regulatory structures. First, the protections for lawful medical marijuana patients and businesses from the Department of Justice provided by the Rohrabacher-Farr budget amendment was temporarily expended […]
Tagged in Banking Access, HF, New Hampshire, SB
Generic
29 April 2017 | 0 Comments
Update: Congress passed a one-week Continuing Resolution, to maintain the current spending levels and Rohrabacher-Farr, meaning state medical marijuana patients and businesses will remain protected from Attorney General Jeff Sessions and the Department of Justice until May 5. Today is the final day that Congress has to pass a short-term budget to fund the federal government […]
Tagged in Continuing Resolution, House Resolution, Rohrabacher Farr, Rohrabacher Farr Amendment
Generic
28 April 2017 | 0 Comments
A recently released white paper published by the National District Attorneys Association is calling for the federal government to strictly enforce anti-cannabis laws in states that have regulated its production and distribution for either medical or recreational purposes. The working group, which consists of D.A.s and prosecutors from more than a dozen states (including representatives […]
Tagged in NDAA
Generic
27 April 2017 | 0 Comments
For more than three decades, supporters of marijuana legalization have gathered in cities across the country on 4/20 to celebrate all things marijuana, and to protest the federal government’s failed War on Drugs. From what started as a loosely organized group of people protesting federal marijuana laws, has now grown into a nationally recognized movement, […]
Tagged in Centre Square, House Bill, Jeff Reidy, Lehigh Valley
Did you know that?
26 April 2017 | 0 Comments
A new study points to cannabis as a trigger for schizophrenia. The research finds that smoking pot or using cannabis in other ways during adolescence may serve as a catalyst for schizophrenia in individuals already susceptible to the disorder.